Watch 9:28
Drug companies aren’t making new antibiotics. Is there an economic cure?
As drug-resistant infections proliferate, financial barriers are preventing the pharmaceutical industry from investing in new drugs to fight off superbugs. Economics correspondent Paul Solman, in a series of reports with science correspondent Miles O'Brien, explores how researchers could be incentivized…
Watch 8:46
The financial barrier to developing antibiotics? No big payday for drug companies
As current antibiotics begin to lose their punch, there’s an economic reality putting a damper on development. Since every use of an antibiotic drives resistance, and doctors are reluctant to use a drug until there's no alternative, why would a…
Watch 9:04
We are running out of effective antibiotics fast
Each year, superbugs -- viral bacterial infections resistant to common antibiotics -- infect more than two million Americans, killing at least 38,000. As the list of antibiotic-resistant bacteria grows, so have the extraordinary efforts to prevent the spread of infection…
Watch 5:48
Armor-like shark skin may offer blueprint for defense against superbugs
Do sharks offer a key to fighting deadly bacteria? The White House unveiled a new campaign Friday to contain drug-resistant bacteria known as “superbugs,” and one of the unlikely resources that researchers are turning to is shark skin. Hari Sreenivasan…
